• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统转录组分析显示非酒精性脂肪性肝病肝脏中酒精代谢基因表达升高。

Systematic transcriptome analysis reveals elevated expression of alcohol-metabolizing genes in NAFLD livers.

机构信息

Department of Bioinformatics, Tongji University, Shanghai, China.

Digestive Diseases and Nutrition Center, Department of Pediatrics, The State University of New York at Buffalo, Buffalo, New York, USA.

出版信息

J Pathol. 2016 Mar;238(4):531-42. doi: 10.1002/path.4650. Epub 2016 Jan 29.

DOI:10.1002/path.4650
PMID:26415102
Abstract

Obese animals and non-alcoholic fatty liver disease (NAFLD) patients exhibit elevated blood alcohol, suggesting potential contributions of alcohol metabolism to the development of NAFLD. Liver gene expression in patients with biopsy-proven mild (N = 40) and severe (N = 32) NAFLD were compared to that in healthy liver donors (N = 7) and alcoholic hepatitis (AH; N = 15) using microarrays. Principal components analyses (PCA) revealed similar gene expression patterns between mild and severe NAFLD which clustered with those of AH but were distinct from those of healthy livers. Differential gene expression between NAFLD and healthy livers was consistent with established NAFLD-associated genes and NAFLD pathophysiology. Alcohol-metabolizing enzymes including ADH, ALDH, CYP2E1, and CAT were up-regulated in NAFLD livers. The expression level of alcohol-metabolizing genes in severe NAFLD was similar to that in AH. The NAFLD gene expression profiles provide new directions for future investigations to identify disease markers and targets for prevention and treatment, as well as to foster our understanding of NAFLD pathogenesis and pathophysiology. Particularly, increased expression of alcohol-metabolizing genes in NAFLD livers supports a role for endogenous alcohol metabolism in NAFLD pathology and provides further support for gut microbiome therapy in NAFLD management. Copyright © 2015 Pathological Society of Great Britain and Ireland. Published by John Wiley © Sons, Ltd.

摘要

肥胖动物和非酒精性脂肪性肝病 (NAFLD) 患者的血液酒精含量升高,表明酒精代谢可能对 NAFLD 的发展有一定的影响。采用微阵列技术比较了经活检证实的轻度(N=40)和重度(N=32)NAFLD 患者、健康供体肝脏(N=7)和酒精性肝炎(AH;N=15)的肝脏基因表达情况。主成分分析(PCA)显示,轻度和重度 NAFLD 的基因表达模式相似,与 AH 的基因表达模式聚类,但与健康肝脏的基因表达模式不同。NAFLD 与健康肝脏之间的差异基因表达与已建立的与 NAFLD 相关的基因和 NAFLD 病理生理学一致。NAFLD 肝脏中包括 ADH、ALDH、CYP2E1 和 CAT 在内的酒精代谢酶上调。严重 NAFLD 中酒精代谢基因的表达水平与 AH 相似。NAFLD 的基因表达谱为未来的研究提供了新的方向,以确定疾病标志物和预防治疗靶点,并促进我们对 NAFLD 发病机制和病理生理学的理解。特别是,NAFLD 肝脏中酒精代谢基因的表达增加支持内源性酒精代谢在 NAFLD 发病机制中的作用,并为 NAFLD 管理中的肠道微生物组治疗提供了进一步的支持。版权所有 © 2015 英国和爱尔兰病理学会。John Wiley & Sons,Ltd. 出版。

相似文献

1
Systematic transcriptome analysis reveals elevated expression of alcohol-metabolizing genes in NAFLD livers.系统转录组分析显示非酒精性脂肪性肝病肝脏中酒精代谢基因表达升高。
J Pathol. 2016 Mar;238(4):531-42. doi: 10.1002/path.4650. Epub 2016 Jan 29.
2
Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients.比较非酒精性脂肪性肝病小鼠模型和患者肝组织的基因表达谱。
Gastroenterology. 2016 Sep;151(3):513-525.e0. doi: 10.1053/j.gastro.2016.05.051. Epub 2016 Jun 16.
3
Induction of CYP2E1 in non-alcoholic fatty liver diseases.非酒精性脂肪性肝病中CYP2E1的诱导
Exp Mol Pathol. 2015 Dec;99(3):677-81. doi: 10.1016/j.yexmp.2015.11.008. Epub 2015 Nov 10.
4
Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.与健康正常体重个体相比,不同程度非酒精性脂肪性肝病患者的肝转录组特征。
Am J Physiol Gastrointest Liver Physiol. 2019 Apr 1;316(4):G462-G472. doi: 10.1152/ajpgi.00358.2018. Epub 2019 Jan 17.
5
Selective insulin resistance with differential expressions of IRS-1 and IRS-2 in human NAFLD livers.选择性胰岛素抵抗与 IRS-1 和 IRS-2 在人非酒精性脂肪性肝病肝脏中的差异表达。
Int J Obes (Lond). 2018 Sep;42(9):1544-1555. doi: 10.1038/s41366-018-0062-9. Epub 2018 May 1.
6
A targeted analysis reveals relevant shifts in the methylation and transcription of genes responsible for bile acid homeostasis and drug metabolism in non-alcoholic fatty liver disease.一项靶向分析揭示了非酒精性脂肪性肝病中负责胆汁酸稳态和药物代谢的基因在甲基化和转录方面的相关变化。
BMC Genomics. 2016 Jun 14;17:462. doi: 10.1186/s12864-016-2814-z.
7
Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances.非酒精性脂肪性肝病的动物模型:当前观点与最新进展
J Pathol. 2017 Jan;241(1):36-44. doi: 10.1002/path.4829. Epub 2016 Nov 22.
8
Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters.非酒精性脂肪性肝病(NAFLD)——发病机制、分类以及对药物代谢酶和转运体的影响
Drug Metab Rev. 2017 May;49(2):197-211. doi: 10.1080/03602532.2017.1293683. Epub 2017 Mar 17.
9
Roles of microRNAs in immunopathogenesis of non-alcoholic fatty liver disease revealed by integrated analysis of microRNA and mRNA expression profiles.通过microRNA和mRNA表达谱的综合分析揭示microRNA在非酒精性脂肪性肝病免疫发病机制中的作用
Hepatobiliary Pancreat Dis Int. 2017 Feb;16(1):65-79. doi: 10.1016/s1499-3872(16)60098-x.
10
Metformin-Induced Changes of the Coding Transcriptome and Non-Coding RNAs in the Livers of Non-Alcoholic Fatty Liver Disease Mice.二甲双胍诱导非酒精性脂肪性肝病小鼠肝脏中编码转录组和非编码RNA的变化
Cell Physiol Biochem. 2018;45(4):1487-1505. doi: 10.1159/000487575. Epub 2018 Feb 16.

引用本文的文献

1
Significant predictors of clinical outcomes in metabolic associated fatty liver disease-related hepatocellular carcinoma following hepatectomy.肝切除术后代谢相关脂肪性肝病相关肝细胞癌临床结局的重要预测因素
Medicine (Baltimore). 2025 Jul 11;104(28):e43248. doi: 10.1097/MD.0000000000043248.
2
Alcohol-Metabolizing Enzymes, Liver Diseases and Cancer.酒精代谢酶、肝脏疾病与癌症
Semin Liver Dis. 2025 Mar;45(1):99-113. doi: 10.1055/a-2551-3320. Epub 2025 Mar 29.
3
A multi-omic landscape of steatosis-to-NASH progression.从肝脂肪变性到非酒精性脂肪性肝炎进展的多组学全景图。
Life Metab. 2022 Dec 1;1(3):242-257. doi: 10.1093/lifemeta/loac034. eCollection 2022 Dec.
4
The Role of RNA Splicing in Liver Function and Disease: A Focus on Metabolic Dysfunction-Associated Steatotic Liver Disease.RNA 剪接在肝脏功能和疾病中的作用:以代谢功能障碍相关脂肪性肝病为例。
Genes (Basel). 2024 Sep 8;15(9):1181. doi: 10.3390/genes15091181.
5
HBV infection may sensitize patients to alcoholic steatohepatitis and non-alcoholic steatohepatitis.乙肝病毒感染可能会使患者对酒精性脂肪性肝炎和非酒精性脂肪性肝炎敏感。
Gastroenterol Rep (Oxf). 2024 Mar 28;12:goae018. doi: 10.1093/gastro/goae018. eCollection 2024.
6
Machine Learning-Based Assessment of Survival and Risk Factors in Non-Alcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma for Optimized Patient Management.基于机器学习的非酒精性脂肪性肝病相关肝细胞癌生存及危险因素评估以优化患者管理
Cancers (Basel). 2024 Mar 10;16(6):1114. doi: 10.3390/cancers16061114.
7
Mechanistically based blood proteomic markers in the TGF-β pathway stratify risk of hepatocellular cancer in patients with cirrhosis.基于机制的TGF-β信号通路血液蛋白质组学标志物可对肝硬化患者肝细胞癌的风险进行分层。
Genes Cancer. 2024 Feb 1;15:1-14. doi: 10.18632/genesandcancer.234. eCollection 2024.
8
"Alphabet" Selenoproteins: Implications in Pathology."Alphabet" 硒蛋白:病理学意义。
Int J Mol Sci. 2023 Oct 19;24(20):15344. doi: 10.3390/ijms242015344.
9
Association between Alcohol Consumption and Metabolic Dysfunction-Associated Steatotic Liver Disease Based on Alcohol Flushing Response in Men: The Korea National Health and Nutrition Examination Survey 2019-2021.基于男性酒精性面红反应的饮酒与代谢相关脂肪性肝病的关系:2019-2021 年韩国国家健康和营养检查调查。
Nutrients. 2023 Sep 7;15(18):3901. doi: 10.3390/nu15183901.
10
Innovative Therapeutic Approaches in Non-Alcoholic Fatty Liver Disease: When Knowing Your Patient Is Key.非酒精性脂肪性肝病的创新治疗方法:了解您的患者是关键。
Int J Mol Sci. 2023 Jun 27;24(13):10718. doi: 10.3390/ijms241310718.